Resources
- FAQ
- Protocol
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- How to Handle Mycoplasma in Cell Culture?
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Assess the Migratory and Invasive Capacity of Cells?
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- CHO Cell Line Development
- How to Isolate PBMCs from Whole Blood?
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Comparison of the MSCs from Different Sources
- Tips For Cell Cryopreservation
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- T Cell Activation and Expansion
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What are the Differences Between M1 and M2 Macrophages?
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Quantification of Cytokines
- IL-12 Family Cytokines and Their Immune Functions
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- STR Profiling—The ID Card of Cell Line
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- Contamination of Cell Cultures & Treatment
- Cell Culture Medium
- What Are Myeloid Cell Markers?
- Cryopreservation of Cells Step by Step
- Cell Cryopreservation Techniques and Practices
- Human Primary Cells: Definition, Assay, Applications
- How to Eliminate Mycoplasma From Cell Cultures?
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- Direct vs. Indirect Cell-Based ELISA
- What Is Cell Proliferation and How to Analyze It?
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- How to Decide Between 2D and 3D Cell Cultures?
- Neural Differentiation from Induced Pluripotent Stem Cells
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- CFU Assay for Hematopoietic Cell
- What are PBMCs?
- How to Start Your Culture: Thawing Frozen Cells
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Techniques for Cell Separation
- Optimization Strategies of Cell-Based Assays
- Immunogenicity Testing: ELISA and MSD Assays
- 3D-Cell Model in Cell-Based Assay
- Types of Cell Therapy for Cancer
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- Cell-Based High-Throughput Screening Techniques
- What Are CAR T Cells?
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Understanding Immunogenicity Assays: A Comprehensive Guide
- 3D-Cell Model in Cell-Based Assay
- Role of Cell-Based Assays in Drug Discovery and Development
- Immunogenicity Testing: ELISA and MSD Assays
- Optimization Strategies of Cell-Based Assays
- Adherent and Suspension Cell Culture
- Organoid Drug Screening
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- From Specimen to Slide: Core Methods in Histological Practice
- Modern Histological Techniques
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- Overview of Cell Apoptosis Assays
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- Cell Viability, Proliferation and Cytotoxicity Assays
-
Histology
- Multiple Animal Tissue Arrays
- Tips for Choosing the Right Protease Inhibitor
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- Troubleshooting in Fluorescent Staining
- Fluorescent Nuclear Staining Dyes
- Stains Used in Histology
- Guides for Live Cell Imaging Dyes
- Overview of the FFPE Cell Pellet Product Lines
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Cell Lysates: Composition, Properties, and Preparation
- Microscope Platforms
- Mitochondrial Staining
- How to Apply NGS Technologies to FFPE Tissues?
- Overview of Common Tracking Labels for MSCs
- Comparison of Membrane Stains vs. Cell Surface Stains
- Immunohistochemistry Controls
-
Exosome
- Exosomes as Emerging Biomarker Tools for Diseases
- How to Apply Exosomes in Clinical?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
- What's the Potential of PELN in Disease Treatment?
- Emerging Technologies and Methodologies for Exosome Research
- Summary of Approaches for Loading Cargo into Exosomes
- How to Perform Targeted Modification of Exosomes?
- How to Enhancement Exosome Production?
- How to Label Exosomes?
- How to characterize exosomes?
- Classification, Isolation Techniques and Characterization of Exosomes
- Exosome Quality Control: How to Do It?
- The Role of Exosomes in Cancer
- Techniques for Exosome Quantification
- Exosome Size Measurement
- What are the Functions of Exosomal Proteins?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- Unraveling Biogenesis and Composition of Exosomes
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- Exosome Transfection for Altering Biomolecular Delivery
- How Important are Lipids in Exosome Composition and Biogenesis?
- Collection of Exosome Samples and Precautions
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Exosome Antibodies
- Common Techniques for Exosome Nucleic Acid Extraction
-
ISH/FISH
- What Types of Multicolor FISH Probe Sets Are Available?
- What Is the Use of FISH in Solid Tumors?
- Mapping of Transgenes by FISH
- Reagents Used in FISH Experiments
- ISH probe labeling method
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- Telomere Length Measurement Methods
- FISH Tips and Troubleshooting
- Multiple Approaches to Karyotyping
- RNAscope ISH Technology
- CARD-FISH: Illuminating Microbial Diversity
- What are the Differences between FISH, aCGH, and NGS?
- Overview of Oligo-FISH Technology
- Differences Between DNA and RNA Probes
- Comparative Genomic Hybridization and Its Applications
- Small RNA Detection by ISH Methods
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Guidelines for the Design of FISH Probes
- How to Use FISH in Hematologic Neoplasms?
- Different Types of FISH Probes for Oncology Research
- What are Single, Dual, and Multiplex ISH?
- Overview of Common FISH Techniques
- In Situ Hybridization Probes
-
Toxicokinetics & Pharmacokinetics
- How to Improve Drug Plasma Stability?
- What Are Metabolism-Mediated Drug-Drug Interactions?
- Pharmacokinetics of Therapeutic Peptides
- Toxicokinetics vs. Pharmacokinetics
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- Experimental Methods for Identifying Drug-Drug Interactions
- Organ-on-a-Chip Systems for Drug Screening
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- Key Considerations in Toxicokinetic
- Methods of Parallel Artificial Membrane Permeability Assays
- How to Conduct a Bioavailability Assessment?
- Overview of In Vitro Permeability Assays
- Traditional vs. Novel Drug Delivery Methods
- Predictive Modeling of Metabolic Drug Toxicity
- The Rise of In Vitro Testing in Drug Development
- What Are Compartment Models in Pharmacokinetics?
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- What factors influence drug distribution?
- How to Design and Synthesize Antibody Drug Conjugates?
- Key Factors Influencing Brain Distribution of Drugs
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Physical and Chemical Properties of Drugs and Calculations
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- Unraveling the Role of hERG Channels in Drug Safety
-
Disease Models
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Preclinical Models of Acute Liver Failure
- Summary of Advantages and Limitations of Different Oncology Animal Models
- Why Use PDX Models for Cancer Research?
- Disease Models of Diabetes Mellitus
- Animal Models of Neurodegenerative Diseases
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter
Protocol of pcDNA3.1-GFP Transfection Cells
GUIDELINE
The liposome transfection method refers to the positively charged surface of cationic liposomes, which can be with the phosphate of nucleic acids through electrostatic interaction of DNA molecules wrapped into the formation of DNA a lipid complex, by the surface of the negatively charged cell membrane adsorption, and then through the fusion of the membrane, and occasionally through the direct penetration of the role of the DNA delivery into the cell, the formation of inclusion bodies or into the lysosomes A small portion of the DNA can be released from the inclusion body and into the cytoplasm, and further into the nucleus of the transcription, expression.
METHODS
- The day before transfection, cells are trypsin digested and counted, and cells are plated so that their density is 90% on the day of transfection. Cells are plated in 0.5 mL of normal growth medium containing serum and no antibiotics.
- For each well of cells, dilute 0.8 μg-1.0 μg of DNA using 50 μL of serum-free DMEM medium. Batch preparation is possible for multi-well operation.
- For each well, dilute 1-3 μL of LIPOFECTAMINE 2000 Reagent with 50 μL of DMEM medium. After dilution with LIPOFECTAMINE 2000, mix with the diluted DNA within 5 minutes. Prolonged holding time reduces activity.
- Mix diluted DNA (from step 2) and diluted LIPOFECTAMINE 2000 (from step 3). Hold at room temperature for 20 minutes.
- Add the complex directly to each well, shake the plate, and mix gently.
- Hold at 37°C in 5% CO2 for 24-48 hours without removing the complex changing the medium or changing the growth medium after 4-5 hours without decreasing the transfection activity.
- Add the complex to the cells.
- After 24-72 hours of adding the complex to the cells, analyze cell extracts or perform in situ cell staining to detect reporter gene activity. This is dependent on cell type and promoter activity. For stable expression, cells are passaged into a fresh medium one day after starting transfection, and screening antibiotics are added two days later. Several days or weeks are required to perform stable expression.
NOTES
- Transfection is not possible with a culture medium containing serum, which has a great impact on transfection efficiency.
- Use a double-antibody-free medium when spreading plates before transfection, the increase in resistance will affect the transfection efficiency.
- Transfection is performed within 24 hours of plate laying.
- Be gentle throughout the operation and avoid violent shaking.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.